NDC 0078-0827-61 Beovu
Brolucizumab
NDC Package Code 0078-0827-61
The NDC Code 0078-0827-61 is assigned to a package of 1 vial, single-dose in 1 carton > .05 ml in 1 vial, single-dose of Beovu, a human prescription drug labeled by Novartis Pharmaceuticals Corporation. The product's dosage form is injection, solution and is administered via intravitreal form.This product is billed per "ML" milliliter and contains an estimated amount of 0.05 billable units per package.
NDC Code Structure
- 0078 - Novartis Pharmaceuticals Corporation
- 0078-0827 - Beovu
- 0078-0827-61 - 1 VIAL, SINGLE-DOSE in 1 CARTON
- 0078-0827 - Beovu
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 0078-0827-61 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
00078082761 | J0179 | Inj, brolucizumab-dbll, 1 mg | 1 MG | 0.05 | 1 | 6 | 6 |
* Please review the disclaimer below.
Other Product Packages
The following packages are also available for Beovu with product NDC 0078-0827.
NDC Package Code | Package Description |
---|---|
0078-0827-60 | 1 SYRINGE, GLASS in 1 CARTON > .05 mL in 1 SYRINGE, GLASS |
0078-0827-98 | 1 SYRINGE, GLASS in 1 CARTON > .05 mL in 1 SYRINGE, GLASS |
0078-0827-99 | 1 VIAL, SINGLE-DOSE in 1 CARTON > .05 mL in 1 VIAL, SINGLE-DOSE |
* Please review the disclaimer below.